Form 8-K Acadia Healthcare Compan For: May 23
http://archive.fast-edgar.com/20240524/AW2VL22DZZ2R3JZU22982ZYQF5PRZZ22Z262
Filed on: May 24, 2024
Form DEFR14A LifeMD, Inc.
http://archive.fast-edgar.com/20240524/AK2OG22CZM2RM2T2222K2MY2BBIDZZ22G262
Filed on: May 24, 2024
Form SD ZimVie Inc.
http://archive.fast-edgar.com/20240524/A82BK22DZZ2R8JZU229G2ZYQM8BDZZ22Z262
Filed on: May 24, 2024
Form 8-K Finward Bancorp For: May 24
http://archive.fast-edgar.com/20240524/AKZDO22CZC22K2ZZ2K2B2MZZN9QMZ6V8Z262
Filed on: May 24, 2024
Form 4 APA Corp For: May 22 Filed by: Ragauss Peter A
http://archive.fast-edgar.com/20240524/AIZFR22CZ222R2A2222F22Z29AT9Z92SB262
Filed on: May 24, 2024
More SEC Filings
View Older Stories-
Form 10-Q Infinera Corp For: Mar 30
-
Form 8-K IMAC Holdings, Inc. For: May 23
-
Form 4 Glimpse Group, Inc. For: May 23 Filed by: Bentovim Lyron L
-
Form 4 APA Corp For: May 22 Filed by: McKay Lamar
-
Form D PI-0425 Fund I, a series
-
Form 4 APA Corp For: May 22 Filed by: Joung Chansoo
-
Form SC 13D/A BriaCell Therapeutics Filed by: L5 Capital Inc.
-
Form 6-K PETROBRAS - PETROLEO For: Jun 30
-
Form 4 APA Corp For: May 22 Filed by: Hooper Charles W
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form 4 APA Corp For: May 22 Filed by: Ellis Juliet S
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form 8-K/A Allarity Therapeutics, For: May 14
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P Principal Real Asset For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form NPORT-P PRINCIPAL VARIABLE CONTR For: Mar 31
-
Form 4 Accolade, Inc. For: May 22 Filed by: Cavanaugh Robert N